TRANS MYOMETRIAL INJECTION OF AUTOLOGOUS MESENCHYMAL STEM CELLS IMPROVES ENDOMETRIAL QUALITY AND ART RESULTS IN PATIENTS WITH REFRACTORY ENDOMETRIUM OR ASHERMAN'S SYNDROME
article
OA: closed
CC0
AI-generated summary
Transmyometrial injection of autologous mesenchymal stem cells improves endometrial quality and assisted reproductive technology outcomes in patients with refractory endometrium or Asherman’s syndrome.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK